At Alstronix
Technologies, Research & Development is at the heart of everything
we do. Our mission is to pioneer transformative innovations in
genomics that are not only scientifically advanced but also culturally and
clinically relevant to the Indian population.
Through our R&D division, we
explore new frontiers in AI-powered genomics, population genetics, and
precision healthcare, building solutions that will shape the future of
medicine, diagnostics, and discovery.
Our in-house AI models are
designed to:
·
Prioritize disease-causing variants
·
Predict gene-disease associations
·
Learn from evolving clinical databases
·
Translate unstructured data (clinical notes,
literature) into actionable insights
We are developing AI-driven
tools to study gene-drug interactions in the Indian
context—bridging the gap between genotype and therapy by:
·
Mapping drug response patterns
·
Identifying risk alleles for adverse drug
reactions
·
Recommending optimized treatments based on
individual genomes
· Variant Impact Prediction using Deep Learning
·
AI
for Rare Disease Detection in Neonatal ICU Settings
·
Multi-omics
Integration for Complex Disease Risk Modeling
·
Big Data Analytics for Population-Scale
Genomics
·
Collaborative
Genomic Studies with Hospitals and Universities
We collaborate with:
·
Academic institutions and genomics researchers
·
Hospitals and clinical diagnostic labs
·
Government health programs
·
Biotech startups and pharma companies
·
Global AI and genomics innovators
Our team includes
bioinformaticians, geneticists, AI researchers, clinicians, and data
scientists—working in an agile, innovation-first environment.
R&D at Alstronix is not just about innovation—it's about making genomics inclusive, accessible, and applicable to the unique challenges of Indian healthcare and global population studies.
If you’re a research
institution, hospital, startup, or government agency looking to drive impactful
genomic innovation, we invite you to collaborate.